| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 |
| filingDate |
2014-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a53588ebecf25211d00b0284e0d08a51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d8aa7d49c803a2d45fff96a4817704e |
| publicationDate |
2017-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2639793-T3 |
| titleOfInvention |
CDC7 inhibitors |
| abstract |
A compound that is 3- (5-fluoropyrimidin-4-yl) -3-methyl-6- (1 H -pyrazol-4-yl) isoindolin-1-one, or a pharmaceutically acceptable salt or hydrate thereof. |
| priorityDate |
2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |